OrthoSpineNews

MARCH 3, 2025

patient in its Investigational Device Exemption (IDE) clinical trial for the PerQdisc Nucleus Replacement Device (NRD). based trial to evaluate its PerQdisc system for patients suffering from degenerative disc disease (DDD). “This is an exciting time for SST as we expand our clinical research into the U.S.

Degenerative Disc Disease

OrthoSpineNews

JUNE 25, 2025

” This trailblazing surgery signals a shift in how spine disorders, particularly those involving nerve pain, disc herniation, degenerative disc disease, and spinal stenosis, can be addressed.

Degenerative Disc Disease

OrthoSpineNews

JULY 29, 2025

a leader in developing and delivering innovative allografts, today announced that it has completed subject enrollment in its ASCEND clinical trial evaluating VIA Disc NP for symptomatic degenerative disc disease (DDD), a condition strongly associated with chronic lower back pain.

Degenerative Disc Disease

OrthoSpineNews

JUNE 17, 2025

“This share repurchase program reflects our confidence in the strength of our clinical development pipeline and the future outlook of our business,” said Lance Alstodt, Chief Executive Officer of BioRestorative. MELVILLE, N.Y., June 17, 2025 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. We have also obtained U.S.

Degenerative Disc Disease

OrthoSpineNews

JUNE 23, 2025

Food and Drug Administration (FDA) premarket approval (PMA) of PearlMatrix P-15 Peptide Enhanced Bone Graft as a Class III drug-device combination product for use in single-level transforaminal lumbar interbody fusion (TLIF) surgery in adult patients with degenerative disc disease (DDD). 3 The ASPIRE trial included 33 U.S.

Degenerative Disc Disease

OrthoSpineNews

JULY 8, 2025

This transaction places Paradigm Spine with a team of people who are well-equipped to complete the remaining clinical and regulatory work and take these fantastic technologies to the next level. We look forward to completing this transaction in a timely manner.” ” Anthony G.

Spine

OrthoSpineNews

SEPTEMBER 24, 2024

a development stage company committed to non-opiate, non-surgical therapies for Degenerative Disc Disease (DDD), today announced the completion of enrollment of its U.S. Phase 3 clinical trial of SB-01 For Injection (SB-01). NEW YORK, September 24, 2024 –(BUSINESS WIRE)– Spine BioPharma, Inc.,

Degenerative Disc Disease

OrthoSpineNews

JULY 16, 2024

Receives FDA acceptance on Phase III clinical protocols for parallel pivotal and confirmatory trials Achieves alignment with FDA on Chemistry, Manufacturing, and Controls (CMC) aspects of Phase III program SALT LAKE CITY, July 16, 2024 /PRNewswire/ — DiscGenics, Inc.,

Degenerative Disc Disease

OrthoSpineNews

JULY 11, 2024

July 11, 2024 /PRNewswire/ — Providence Medical Technology announces FDA Clearance of its CORUS™ Posterior Cervical Stabilization System (PCSS) for the treatment of up to 3-level cervical Degenerative Disc Disease (DDD).

Degenerative Disc Disease

Any Spine

SEPTEMBER 30, 2024

They assess and treat conditions like degenerative disc disease and other musculoskeletal disorders through tailored spinal adjustments. They address conditions like degenerative disc disease. Chiropractors assess and treat spinal alignment issues. Chiropractic adjustments can relieve symptoms like nausea.

Spinal Adjustment

Smart Pain Solutions

JULY 11, 2023

If you are interested in learning more clinically about Upper Cross we advise you to take a look at Physiopedia’s informational page! Degenerative Changes : Conditions such as osteoarthritis and degenerative disc disease are normal complications that arise with getting old.

Posture

Any Spine

OCTOBER 1, 2024

Occurrences of degenerative disc disease are common where the intervertebral discs lose their flexibility, leading to chronic back pain and reduced mobility. Conditions like degenerative disc disease, spinal disc herniation , and spinal stenosis are significant contributors.

Spine

Any Spine

OCTOBER 10, 2024

How Spinal Manipulation Alleviates Pain Spinal manipulation is a key component of chiropractic care that can effectively alleviate pain associated with conditions like degenerative disc disease and radiculopathy. Targets conditions like degenerative disc disease and radiculopathy.

Back Pain Relief

Smart Pain Solutions

MAY 16, 2023

We will discuss decompression tables and exercises that can be performed in-clinic and at home. Smart Pain Solutions is a chiropractic clinic. Louis chiropractic offices in Bridgeton and Clayton use decompression to reduce pressure placed on the body’s joints, spinal nerves, discs, and surrounding vertebrae.

Spinal Decompression Therapy

The Evidence Based Chiropractor

OCTOBER 11, 2021

We are all familiar with the 80 – 10 – 10 Rule in clinical practice: 80% of our patients meet our recovery expectations, 10% of our patients may meet only a partial recovery, and the other 10% of our patients we may either have referred them out upon detecting a red flag on their examination, or they just did not respond to care.

Degenerative Disc Disease

Any Spine

OCTOBER 16, 2024

Our Atlanta-based clinic offers comprehensive services, from initial diagnosis to personalized treatment plans, and accepts various insurance options to ensure your path to wellness is accessible. Located conveniently in Atlanta, GA, the clinic offers a holistic health solution tailored specifically to individual needs.

Health

Any Spine

OCTOBER 22, 2024

Limitations of Traditional Treatments In my professional experience, I’ve observed the limitations of traditional treatments which often provide a temporary respite rather than a lasting solution for conditions such as degenerative disc disease.

Back Pain Relief

Any Spine

SEPTEMBER 30, 2024

Clinical trials have shown the effectiveness of chiropractic spinal adjustments in reducing pain, including issues in the shoulder area, often providing a complementary option alongside other treatments like acupuncture.

Spinal Adjustment

Any Spine

SEPTEMBER 30, 2024

The subsequent sections delve into each of these advantages, backed by clinical trials and randomized controlled trial findings. Additionally, they can lead to a significant reduction in reliance on pain medications, ultimately improving overall quality of life.

Spinal Adjustment

Any Spine

NOVEMBER 7, 2024

We’ll discuss how these therapies can help manage pain, the variety of conditions they effectively address, and what to expect when you visit a clinic like Any Spine Chiropractic & Massage Studio for the first time. Massage therapy is a key component of our integrated approach to wellness.

Massage

Any Spine

OCTOBER 21, 2024

How Combining Both Therapies Enhances Overall Well-Being Integrating chiropractic care, with its emphasis on spinal manipulation, and massage therapy within a clinic setting offers a comprehensive approach that significantly improves the quality of life for patients suffering from conditions such as carpal tunnel syndrome and sciatica.

Massage

Any Spine

SEPTEMBER 29, 2024

This practice, focusing on the body’s natural healing capabilities, is especially beneficial for those with degenerative disc disease, as it aligns the spinal structure, enhancing mobility and lessening weakness without the need for surgical intervention.

Spine

OrthoSpineNews

JANUARY 7, 2025

a development stage company committed to non-opiate, non-surgical therapies for Degenerative Disc Disease (DDD), today announced that Chief Executive Officer Marc Viscogliosi will present a corporate overview and update at Biotech Showcase 2025, taking place in San Francisco January 13-15.

Degenerative Disc Disease

OrthoSpineNews

MARCH 10, 2025

This prospective, multi-center, multi-specialty clinical trial is the first of its kind to evaluate the safety and efficacy of lumbar interlaminar fusion devices, marking a significant milestone in the advancement of spinal care. CARLSBAD, Calif.,

Degenerative Disc Disease

OrthoSpineNews

JUNE 13, 2025

Compelling Clinical Signals: Over 74% of subjects showed >50% improvement in function (ODI) by 52 weeks; Over 72% of subjects reported >50% reduction in pain (VAS) by 52 weeks; Combined >50% improvement in both ODI and VAS measures was achieved by a meaningful portion of subjects across all timepoints. We have also obtained U.S.

Degenerative Disc Disease

OrthoSpineNews

JANUARY 28, 2025

Spinal disorders, particularly those related to intervertebral discs, have become one of the leading causes of disability and chronic pain across the globe. The prosthetic disc nucleus provides a promising solution for patients suffering from degenerative disc disease, offering an alternative to traditional spinal fusion surgeries.

Degenerative Disc Disease

OrthoSpineNews

MAY 14, 2025

We have continued to execute well across our business, including the achievement of key clinical program milestones, since the start of 2025, said Lance Alstodt, the Companys Chief Executive Officer. We have commenced a Phase 2 clinical trial using BRTX-100 to treat chronic lower back pain arising from degenerative disc disease.

Degenerative Disc Disease

OrthoSpineNews

FEBRUARY 10, 2025

Segment Overview This spinal implants market report extensively covers market segmentation by Product Spinal Fusion Implants Non-fusion Spinal Implants End-user Hospitals Ambulatory Surgical Centers Specialty Clinics Geography North America Europe Asia Rest Of World (ROW) 1.1

Degenerative Disc Disease

MyChiroPractice

MAY 28, 2025

Branding & Authority Consistent, valuable communication positions your clinic as a leading expert and reliable source of health information in your community. Use high-quality photos of your team, clinic, or demonstrations of exercises. In a crowded healthcare marketplace, establishing this kind of authority is invaluable.

Patients